Mark Mallon | Chief Executive Officer |
George Cardoza | President, Lab Operations and COO |
Doug Brown | Chief Strategy and Corporate Development Officer |
Charlie Eidson | Director, Investor Relations |
Dr. Gina Wallar | President, Pharma Services Division |
Dr. Clive Morris | President, Inivata |
Kathryn McKenzie | Chief Financial Officer |
Bill Bonello | President, Informatics |
Andrew Cooper | Raymond James |
David Westenberg | Guggenheim Securities |
Puneet Souda | SVB Leerink |
Mark Massaro | BTIG |
Griffin Soriano | William Blair |
Alex Nowak | Craig-Hallum Capital Group |
Derik De Bruin | Bank of America |
Matt Sykes | Goldman |
Tejas Savant | Morgan Stanley |
Mike Matson | Needham |
Good morning, ladies and gentlemen. And welcome to the NeoGenomics Third Quarter 2021 Earnings Call. At this time, all participants have been placed on a listen-only and the floor will be open for questions-and-comments after the presentation. It is now my pleasure to turn the floor over to your host, CEO, Mark Mallon. Sir, the floor is yours.